You are here

Takeda

With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay

Fierce Pharma

Wed, 12/22/21 - 11:11 am

eosinophilic esophagitis

FDA clears Takeda drug for post-transplant CMV infections

Pharmaforum

Wed, 11/24/21 - 10:06 am

post-transplant CMV

Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf

Fierce Biotech

Wed, 11/10/21 - 10:22 am

Poseida Therapeutics

Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come

Fierce Pharma

Mon, 11/8/21 - 10:54 am

value-based pricing

Takeda to buy GammaDelta to accelerate allogeneic cell therapies development

Pharmaceutical Business Review

Thu, 10/28/21 - 10:37 am

GammaDelta Therapeutics

allogeneic cells

Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform

Fierce Biotech

Fri, 10/22/21 - 12:10 pm

Egle Therapeutics

Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work

Endpoints

Tue, 10/19/21 - 10:51 am

Wave Life Sciences

Calithera buys itself a plan B

EP Vantage

Tue, 10/19/21 - 10:43 am

Calithera Biosciences

B cell lymphoma

Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft

MedCity News

Thu, 10/14/21 - 11:04 am

B cell therapies

Poseida, Takeda partner to develop eight in vivo gene therapy programs

Pharmaceutical Business Review

Wed, 10/13/21 - 10:51 am

Poseida Therapeutics

drug development

FDA offers support for Takeda's potential cytomegalovirus drug ahead of adcomm

Endpoints

Wed, 10/6/21 - 11:17 pm

post-transplant cytomegalovirus

Takeda halts trial of orexin drug in narcolepsy on safety grounds

Pharmaforum

Wed, 10/6/21 - 10:52 am

clinical trials

Roche, Takeda and Pfizer notch top scores among rare disease patient advocacy groups

Fierce Pharma

Mon, 10/4/21 - 11:03 am

patient advocacy groups

Takeda taps Selecta for $1.1B gene therapy research pact

Fierce Biotech

Mon, 10/4/21 - 10:43 am

Selecta Biosciences

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

Pharmaforum

Mon, 09/27/21 - 10:49 am

Crohn's Disease

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval

Pharmaforum

Thu, 09/16/21 - 10:44 am

Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says

Fierce Pharma

Tue, 09/14/21 - 10:45 pm

Moderna Therapeutics

No dice: Court tells AbbVie it can't force Takeda to supply a drug that's in shortage worldwide

Fierce Pharma

Thu, 09/9/21 - 11:09 am

HilleVax Rakes in $135 Million to Rapidly Progress Norovirus Vaccine

BioSpace

Wed, 09/8/21 - 11:17 pm

Not waving but drowning: Takeda's blood cancer drug flunks phase 3, dealing further blow to hopes of approval flurry

Fierce Biotech

Thu, 09/2/21 - 09:38 am

clinical trials

Pages